These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23190132)

  • 1. Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma.
    Lemma S; Karihtala P; Haapasaari KM; Jantunen E; Soini Y; Bloigu R; Pasanen AK; Turpeenniemi-Hujanen T; Kuittinen O
    Histopathology; 2013 Jan; 62(2):326-33. PubMed ID: 23190132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas.
    Uotila PM; Lemma SA; Haapasaari KM; Porvari K; Skarp S; Soini Y; Jantunen E; Turpeenniemi-Hujanen T; Kuittinen O
    Hematology; 2020 Dec; 25(1):241-246. PubMed ID: 32567520
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.
    Wang Y; Li YJ; Jiang WQ; Rao HL; Huang JJ; Xia Y; Bi X; Sun P; Huang HQ; Lin TY; Guan ZZ; Li ZM
    Ann Hematol; 2015 Nov; 94(11):1865-73. PubMed ID: 26327569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factors zeb1, twist and snai1 in breast carcinoma.
    Soini Y; Tuhkanen H; Sironen R; Virtanen I; Kataja V; Auvinen P; Mannermaa A; Kosma VM
    BMC Cancer; 2011 Feb; 11():73. PubMed ID: 21324165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist predicts poor outcome of patients with astrocytic glioma.
    Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
    J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT-associated factors promote invasive properties of uveal melanoma cells.
    Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
    Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.
    Chen Z; Li S; Huang K; Zhang Q; Wang J; Li X; Hu T; Wang S; Yang R; Jia Y; Sun H; Tang F; Zhou H; Shen J; Ma D; Wang S
    Hum Pathol; 2013 Oct; 44(10):2097-105. PubMed ID: 23791009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma.
    Wels C; Joshi S; Koefinger P; Bergler H; Schaider H
    J Invest Dermatol; 2011 Sep; 131(9):1877-85. PubMed ID: 21593765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
    Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
    BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
    Liu H; Wang H; Liu X; Yu T
    Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial mesenchymal-like transition occurs in a subset of cells in castration resistant prostate cancer bone metastases.
    Haider M; Zhang X; Coleman I; Ericson N; True LD; Lam HM; Brown LG; Ketchanji M; Nghiem B; Lakely B; Coleman R; Montgomery B; Lange PH; Roudier M; Higano CS; Bielas JH; Nelson PS; Vessella RL; Morrissey C
    Clin Exp Metastasis; 2016 Mar; 33(3):239-48. PubMed ID: 26667932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer.
    Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W
    Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of transcription factors Snail, Slug, SIP1, and Twist in ameloblastoma.
    Siar CH; Ng KH
    J Oral Pathol Med; 2014 Jan; 43(1):45-52. PubMed ID: 23560539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy.
    Kawamura K; Wada A; Wang JY; Li Q; Ishii A; Tsujimura H; Takagi T; Itami M; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):27-36. PubMed ID: 26077666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor budding at the invasive front of colorectal cancer may not be associated with the epithelial-mesenchymal transition.
    Yamada N; Sugai T; Eizuka M; Tsuchida K; Sugimoto R; Mue Y; Suzuki M; Osakabe M; Uesugi N; Ishida K; Otsuka K; Matsumoto T
    Hum Pathol; 2017 Feb; 60():151-159. PubMed ID: 27836787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
    van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
    Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of p53 aberrations for R-CHOP-treated patients with diffuse large B-cell lymphoma.
    Stefancikova L; Moulis M; Fabian P; Vasova I; Zedek F; Ravcukova B; Muzik J; Kuglik P; Vranova V; Falkova I; Hrabalkova R; Smardova J
    Int J Oncol; 2011 Dec; 39(6):1413-20. PubMed ID: 21874232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY; Weber CE; Mi Z; Wai PY; Cuevas BD; Kuo PC
    J Am Coll Surg; 2013 Jul; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.